Sign In
Buy CASI
$0.208
+0 (+0%)
At Close: May 22, 2026
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that it submi
CASI Pharmaceuticals To Present At The Jefferies 2020 Healthcare Conference
11:00am, Tuesday, 02'nd Jun 2020
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that Dr. Wei-
Do Hedge Funds Love CASI Pharmaceuticals Inc (CASI)?
09:38pm, Sunday, 31'st May 2020
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
Wei-Wu He Is The Chairman & CEO of CASI Pharmaceuticals, Inc. (NASDAQ:CASI) And They Just Picked Up 32% More Shares
10:14am, Monday, 25'th May 2020
Those following along with CASI Pharmaceuticals, Inc. (NASDAQ:CASI) will no doubt be intrigued by the recent purchase...
Casi Pharmaceuticals Inc (CASI) Chairman and CEO Wei-wu He Bought $–94,…96 of Shares
12:00am, Thursday, 21'st May 2020Casi Pharmaceuticals Inc (CASI) Chairman and CEO Wei-wu He Bought $864,696 of Shares
12:00am, Tuesday, 19'th May 2020Earnings Update: CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Just Reported And Analysts Are Boosting Their Estimates
10:47am, Thursday, 14'th May 2020
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) just released its latest first-quarter results and things are looking...
CASI Pharmaceuticals: 2-Year Price Lows Make For Intriguing Risk-On Buy
02:27am, Wednesday, 13'th May 2020
CASI is focused on developing and commercialising drugs for the Chinese market most notably within the field of hematology/oncology using an innovative in-licen
Upgrade: Analysts Just Made A Notable Increase To Their CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Forecasts
10:43am, Tuesday, 12'th May 2020
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) shareholders will have a reason to smile today, with the analysts making...
CASI Pharmaceuticals Announces First Quarter 2020 Financial Results
11:00am, Monday, 11'th May 2020
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial resu
CASI: A Change in Strategy
01:05pm, Friday, 08'th May 2020
By Beth Senko, CFA NASDAQ:CASI READ THE FULL CASI RESEARCH REPORT CASI Pharmaceuticals (NASDAQ:CASI) signaled a shift in its business strategy in March – focusing its efforts on its hematology franc
CASI Pharmaceuticals To Present at 2020 Solebury Trout Virtual Investor Conference
11:00am, Tuesday, 07'th Apr 2020
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that Dr. Wei-
